	Different family caregiver- and care recipient-related factors are associated with the cost of care in the early, mild, and moderate stages of Alzheimer's disease in Finland: A 5-year ALSOVA study. Eur J Health Econ Jetsonen V, Välimäki T, Selander T, Kuvaja-Köllner V, Martikainen J, Koivisto AM. PMID: 42319641 [PubMed - as supplied by publisher]
	RDoC-informed explainable AI as a paradigm for multilevel Alzheimer's disease diagnosis and progression prediction: a systematic review. Brain Inform Nami M, Peebles D, Thabtah F, Kamalov F. PMID: 42319634 [PubMed - as supplied by publisher]
	RNA acetylation modification ac4C: An emerging regulatory hub of RNA metabolism disruption in Alzheimer's disease. Mol Biol Rep Xing L, Liu A, Li J, Jiang K, Li H. PMID: 42319535 [PubMed - indexed for MEDLINE]
	Speech and swallowing rehabilitation in Huntington's disease: clinical outcomes and correlations with disease severity. Neurol Sci Salto, , Turgut F, Ya, Sücüllü Karada. PMID: 42319517 [PubMed - indexed for MEDLINE]
	Digital speech-based markers to advance prognosis in Alzheimer's disease. Alzheimers Dement Lee M, Meylan S, Shobin E, SpeechDx Consortium, Nisenbaum L, Sukumar A, Kourtis L. PMID: 42318897 [PubMed - indexed for MEDLINE]
	Diagnostic performance of plasma p-Tau217, p-Tau181, and p-Tau231 across the Alzheimer's disease continuum: a network meta-analysis. Front Aging Neurosci Chen X, Huang T, Shi C, Xu S, Fan S. PMID: 42318558 [PubMed]
	Plasma lncRNA signature of upregulated ATP2B1-AS1 and downregulated RPL21P28 correlates with diagnosis and cognitive severity in Alzheimer's disease. Front Aging Neurosci Yadollahi Khales A, Ghaedi K, Esmaeili F, Noorbakhshnia M, Etemadifar M. PMID: 42318555 [PubMed]
	Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study. Alzheimers Dement (Amst) Amieva H, Dussartre M, Philipps V, Rouanet A, Dufouil C, Jacqmin-Gadda H, Dartigues JF, Pérès K, Samieri C, Catheline G, Helmer C, Proust-Lima C. PMID: 42318440 [PubMed]
	Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study. Front Neurol Chmiela T, Dulski J, Heckman MG, Fang ZJ, Wszolek ZK, Wilson JR. PMID: 42318251 [PubMed]
	Ethanol exposure and high-fat diet: assessing the neuroimmune and metabolic mechanisms in Alzheimer's disease pathology. Front Neurosci Njoku GC, Saraswathi V. PMID: 42318197 [PubMed]
	Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer's Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study. Neuropsychiatr Dis Treat Wei YT, Li L, Xie WT, Wang Y, Zhao YR, Zhang RZ, Ma L, Yan XK. PMID: 42318047 [PubMed]
	Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer's Disease. Cureus Khangsar LT, Boileau AJ. PMID: 42317938 [PubMed]
	Nano-based spectroscopic approaches for early diagnosis of Alzheimer's disease: critical insights into amyloid-Î² and tau biomarker biology and detection tools. Biophys Rev Tatar AS, Colnita A, Brezestean IA, Boca S. PMID: 42317543 [PubMed]
	Spatial transcriptomics in Alzheimer's disease: technologies, challenges and discoveries. Mol Neurodegener Adv Shi CH, Piña-Crespo JC, Yip KY, Huang TY. PMID: 42317262 [PubMed]
	Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer's Disease Neuroimaging Initiative study. J Int Neuropsychol Soc Matchanova A, Ly MT, Frank C, Zaratan A, Bangen KJ, Bondi MW, Delano-Wood L, Department of Defense Alzheimer. PMID: 42316769 [PubMed - as supplied by publisher]
	Evaluating the accuracy and reliability of telephone-derived Clinical Dementia Rating scores: A comparative analysis with in-person assessments. Alzheimers Dement Assfaw AD, Xiong C, Moulder KL, Morris JC. PMID: 42316378 [PubMed - indexed for MEDLINE]
	Impact of sex differences on microglial function in Alzheimer's disease. Alzheimers Res Ther Figueiredo EV, Azevedo CV, Penitente AR, Pedrosa VR, Camilo da Silva VR, Longo BM. PMID: 42316324 [PubMed - as supplied by publisher]
	Associations of plasma biomarkers of Alzheimer's disease pathology with modifiable risk factors and cognitive and functional outcomes: evidence from cross-sectional prediction and latent path analyses in the Bio-Hermes-001 cohort. Alzheimers Res Ther Kirk M, Kwon J, Mavromati K, Gordon-Boyle A, Bhui K, Koychev I, Bauermeister S, Tsiachristas A. PMID: 42316310 [PubMed - as supplied by publisher]
	Nanoparticles that target nonamyloid and nontau pathways in Alzheimer's disease. Discov Nano Alavian F, Hajimohammadi A. PMID: 42315809 [PubMed]
	Association of Cathepsin Proteins with Alzheimer's Disease Risk: An Integrated Observational and Genetic Analysis. Neuromolecular Med Zhang Q, Li Q, Ai Z, Li F, Wang Y, Zhou W. PMID: 42315799 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 125839

Page 1 of 6292



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy